Trial Profile
Cost Effectiveness Of Linezolid Vs Vancomycin In The Treatment Of Ventilator Acquired Pneumonia In Central America.
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2012
Price :
$35
*
At a glance
- Drugs Linezolid (Primary) ; Vancomycin
- Indications Bacterial infections; Nosocomial pneumonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 29 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 27 Jun 2011 Planned end date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 03 Jun 2011 Planned end date changed from May 2011 to Jun 2011 as reported by ClinicalTrials.gov.